Drug delivery device

Patent metadata

Field	Value
Publication number	US-10960145-B2
Application number	US-201816055863-A
Country	US
Kind code	B2
Filing date	Aug 6, 2018
Priority date	Jul 17, 2012
Publication date	Mar 30, 2021
Grant date	Mar 30, 2021

Abstract

A drug delivery device for setting and dispensing a dose of a drug is presented having a support body having a first end defining a first opening and a second end defining a second opening and a centered outer indicator ring. A syringe barrel sealed by a stopper is slidably diposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly, wherein the syringe barrel is positioned within the support body. A needle shield is adapted to be coupled to one of the ends of the support body and slidably disposed thereon. An outer body is adapted to be coupled to the other end of the support body and slidably disposed thereon, wherein the outer indicator ring limits the movement of the outer body as well as of the needle shield.

First claim

The invention claimed is:

1. A drug delivery device comprising:
a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly;
a needle shield configured to be coupled to the support body and slidably disposed thereon, the needle shield comprising a direction indicator; and
an outer body configured to be coupled to the support body,
wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

2. The drug delivery device of claim 1 , wherein the needle shield comprises a mating surface to couple to the support body.

3. The drug delivery device of claim 1 , further comprising a detent mechanism configured to constrain movement of the needle shield relative to the support body by opposing the movement with a detent force.

4. The drug delivery device of claim 3 , wherein the detent mechanism comprises at least one guiding track defined on the support body and at least one retaining clip on the needle shield deflectable by the at least one guiding track, wherein the at least one guiding track is configured such that the retaining clip follows a first path when the needle shield is depressed for needle extension and a different second path when the needle shield is subsequently extended, wherein a non-return catch is arranged for catching the retaining clip at an end of the second path.

5. The drug delivery device of claim 1 , wherein the support body comprises a guiding slot disposed within a wall of the support body, the guiding slot configured to guide movement of the needle shield.

6. The drug delivery device of claim 1 , wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

7. The drug delivery device of claim 1 , wherein the needle shield comprises a body section and a cap section, the cap section of the needle shield being rotationally locked to the body section of the needle shield.

8. The drug delivery device of claim 7 , wherein the cap section of the needle shield comprises a non-circular cross section configured to engage in a corresponding opening in the body section of the needle shield.

9. A drug delivery device comprising:
a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly;
a needle shield configured to be coupled to the support body and slidably disposed thereon;
a boot remover configured to remove a protective needle boot from a needle, the boot remover comprising a direction indicator; and
an outer body configured to be coupled to the support body, wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

10. The drug delivery device of claim 9 , wherein the boot remover is configured to engage the needle boot by friction or by barbs.

11. The drug delivery device of claim 9 , wherein the boot remover comprises a handle to facilitate boot removal.

12. The drug delivery device of claim 11 , wherein the needle shield comprises an opening in which the needle boot is positioned, wherein the handle extends from the opening.

13. The drug delivery device of claim 9 , wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

14. A drug delivery device comprising:
a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly; and
an outer body configured to be coupled to the support body and slidably disposed thereon, the outer body comprising a direction indicator,
wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

15. The drug delivery device of claim 14 , wherein a portion of the outer body coupled to the support body comprises a radially outwards directed flange.

16. The drug delivery device of claim 14 , wherein the direction indicator comprises a profiled cavity or concavity in a surface of the outer body.

17. The drug delivery device of claim 14 , further comprising a detent mechanism configured to constrain movement of the outer body relative to the support body by opposing the movement with a detent force.

18. The drug delivery device of claim 14 , further comprising the syringe barrel sealed by the stopper and a plunger rod coupled to the stopper, a proximal portion of the plunger rod configured to be coupled to the outer body.

19. The drug delivery device of claim 14 , wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

Assignees

• Sanofi Aventis Deutschland

Inventors

• Harms Michael
• Hofmann Verena
• Roberts Gareth
• Ward Chris
• Wilson Graham

Classifications

• A61M5/3272 Primary

  having projections following labyrinth paths · CPC title

• A61M2205/586

  Ergonomic details therefor, e.g. specific ergonomics for left or right-handed users · CPC title

• A61M5/326

  Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user · CPC title

• A61M2205/583

  by visual feedback · CPC title

• A61M5/3204

  Needle cap remover, i.e. devices to dislodge protection cover from needle or needle hub, e.g. deshielding devices · CPC title